Overview

Treatment of Primary Breast Cancer Using PDT

Status:
Completed
Trial end date:
2017-12-01
Target enrollment:
Participant gender:
Summary
Phase I/IIA, open label, non-randomised, single site trial in patients with primary breast cancer.
Phase:
N/A
Details
Lead Sponsor:
University College, London
Treatments:
Verteporfin